通过伊米基莫德使瘤血管系统正常化:为TLR7激动剂提出了一种新的抗癌治疗指示
Jarosz-Biej Magdalena1, Czapla Justyna2, Ciepła Joanna2
1Center for Translational Research and Molecular Biology of Cancer, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Poland. Magdalena.Jarosz-Biej@gliwice.nio.gov.pl.
Cancer immunology, immunotherapy : CII
|February 1, 2025
概括
伊米基莫德 (IMQ) 是一种托尔类受体7激动剂,在50μg剂量时有效地使瘤血管正常化,减少缺氧并增强抗癌疗法. 较高的剂量被证明是有害的,突出了最佳剂量的协同效应.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 血管生物学 血管生物学
背景情况:
- 伊米基莫德 (IMQ) 是一种类似收费受体7 (TLR7) 激动剂,具有免疫刺激和放射性敏感性.
- 瘤血管系统的异常有助于瘤的进展,缺氧和免疫抑制.
- IMQ对瘤血管系统的确切影响尚不清楚.
研究的目的:
- 为了研究不同剂量的伊米基莫德对黑色素瘤瘤生长和血管系统的影响.
- 为了确定伊米基莫德是否可以使瘤血管正常化并减少缺氧.
- 评估伊米基莫德作为血管正常化剂在癌症治疗中的潜力.
主要方法:
- 黑色素瘤携带的小鼠接受了不同剂量的伊米基莫德 (IMQ) 治疗.
- 评估了瘤生长,血管密度,形度,细胞周围覆盖率和 perfusion.
- 瘤缺氧和T淋巴细胞透被量化.
主要成果:
- 50微克的IMQ剂量最有效地抑制了瘤生长,降低了血管密度.
- IMQ以剂量依赖的方式在结构和功能上使瘤血管正常化,减少缺氧.
- 最佳的IMQ剂量增强了低剂量多克索鲁比辛的疗效,并增加了T淋巴细胞透.
结论:
- 伊米基莫德,特别是50微克,在黑色素瘤中起到血管正常化剂的作用.
- IMQ治疗可以减少瘤缺氧,并促进抗瘤免疫微环境.
- 这些发现支持将IMQ重新用于联合癌症治疗,以改善治疗结果.
相关概念视频
Tumor Immunotherapy
464
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
464
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K


